News
NICE backs Sobi's Tryngolza for rare disease FCS
Patients in England and Wales with familial chylomicronaemia syndrome will soon have a new treatment option, as NICE backs Sobi's Tryngolza.
News
GLOBE model finalised, with narrowed scope and fewer savings
CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.
News
PhRMA hires ex-House Majority Leader Eric Cantor as its CEO
Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
News
FDA clears first drug for MCT8 deficiency
Sweden's Egetis has won approval in the US for the first-ever treatment for people living with the ultra-rare genetic disease MCT8 deficiency.
News
AbbVie's Cerevel takeover delivers Parkinson's approval
The first drug from AbbVie's $8.7 billion takeover of Cerevel two years ago, Parkinson's disease therapy Juvmo, has won FDA approval.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
